Therapy practice buyers can offer capital, administrative support, succession, or a broader clinical network. They can also have very different expectations about your role and how the practice should operate. Before deciding whether an offer is attractive, find out who the buyer is, why your practice fits, and what would change after closing.
Potential acquirers include clinician successors, regional therapy groups, and larger behavioral health platforms. A private equity sponsor may invest through an existing operating platform or support a new one. The relevant buyer universe depends on geography, scale, service mix, and the leadership available after the transaction.
“Who buys mental health practices?” is therefore a matching question. A company that acquires psychiatry groups may not seek a small therapy-only practice. A buyer with a large national presence may still lack an operating plan for your local market. Qualify interest against your actual business.
Ask the buyer to explain the operational reason for the acquisition. It may want local density, additional clinical specialties, recruiting capabilities, or an established team in a new market. A specific answer helps you identify what the buyer values and what resources it expects the practice to contribute.
Then test the answer. If the thesis depends on growth, who recruits and supervises the clinicians? If it depends on cross-referrals, what is the practical process? If the buyer wants the founder’s relationships, how long does it expect you to remain? Strategy should translate into responsibilities.
Identify the acquiring entity, the source of purchase funds, and who has authority to approve the deal. Ask whether lender approval, investment committee approval, or another transaction is still required. The buyer should distinguish funds already available from financing it plans to arrange.
A financing condition does not necessarily disqualify a buyer, but it affects certainty and timing. Compare the proposed exclusivity period with the buyer’s actual approval path. A seller should not discover late in diligence that the person negotiating price cannot authorize it.
Discuss supervision, treatment protocols, scheduling expectations, documentation, and clinical escalation. Ask who appoints the clinical leader and how disagreements between clinical and administrative leadership are resolved. Broad promises about autonomy need a practical operating definition.
Different transaction structures and jurisdictions can create different requirements. Have counsel assess the proposed ownership and management arrangements. The commercial discussion should identify your priorities early, then turn them into appropriate contractual and operational commitments rather than relying on an informal assurance.
Review compensation methodology, benefits, caseload expectations, scheduling flexibility, supervision time, and administrative support. Ask whether employment arrangements will change and when staff will receive details. If a retention program is proposed, clarify who funds it and what conditions apply.
Speak with founders and clinical leaders from earlier acquisitions. Ask what changed after the initial transition and which promises were difficult to implement. Reference calls are most useful when they address specific issues: billing support, recruiting response, clinician turnover, and access to decision-makers.
Request a draft transition plan covering the electronic record, billing, payroll, payer coordination, brand, and local management. Identify which systems change immediately and which remain temporarily. Ask who carries the workload and how the buyer will avoid overwhelming the team during normal clinical operations.
Patient privacy belongs in this plan. HHS: Summary of the HIPAA Privacy Rule describes the HIPAA framework, including safeguards and limits on uses and disclosures. Have the legal and compliance teams specify the lawful process for records access and migration rather than treating an acquisition as unrestricted access to patient information.
Request an offer breakdown showing cash at closing, seller financing, earnouts, escrow, and any equity you retain or receive. If a buyer discusses a “second bite” from a future sale, ask what must happen for that value to materialize and what rights minority owners have.
Rollover equity exposes you to the future performance and capital structure of the buyer’s business. An earnout exposes you to the agreed measurement and payment conditions. Those features can suit some objectives, but they should be assessed as risks and opportunities rather than counted as cash already earned.
Define the distinction between selling ownership and continuing employment. A buyer may need you to lead clinically, recruit, manage, or introduce referral partners. Put expected time commitments, decision rights, compensation, and duration into the discussion before selecting a preferred proposal.
Also address the end of that role. What happens if you become unable to work, disagree with a management change, or finish the transition earlier than expected? Counsel should evaluate how employment terms interact with contingent consideration and equity. A sale should not leave your future dependent on ambiguous expectations.
ARC Health announced its acquisition of Clarity Counseling Center, an outpatient therapy practice in North Carolina, on November 18, 2025. That provides a concrete example of platform interest in therapy operations. See ARC Health: Clarity Counseling Center acquisition, November 18, 2025.
One announcement does not establish every buyer’s current appetite, your expected price, or your likely outcome. Ask an advisor to confirm the relevant parties’ present criteria. Review the 2026 market update for the distinction between public evidence and practice-specific implications.
Record each buyer’s strategic fit, funding status, clinical model, transition plan, and proposed economics. Mark which answers are supported by documents or references. Keep unresolved questions visible rather than averaging them away in a single score.
Compare at least one downside scenario. What if a key clinician leaves, collections slow during migration, or you need to reduce your post-close hours? Ask which party bears the financial consequences and which provisions address the problem. This exercise often reveals more than another discussion of the headline multiple.
The right therapy practice buyers for one founder may be unsuitable for another. An owner seeking a full departure needs a different handoff from an owner who wants to build a larger clinical organization. Clarify your priorities before evaluating the sales pitch.
Use the mental health practice sale guide to organize the process and the deal terms guide to compare proposals. A focused buyer search should leave you with informed choices and a clear understanding of what each choice requires.
Start with your numbers using the behavioral health business valuation calculator, then request a confidential consultation to discuss your practice and goals.
Tony Siebel is the Founder and Managing Director of Olympic M&A, a boutique healthcare M&A advisory firm supporting founder-led businesses. His background includes corporate development and independent practice acquisitions at MDVIP, along with experience in behavioral health transactions.
Tony has advised on $100M+ in completed healthcare M&A transactions and was named a Top 50 M&A Advisor in 2025. Through Olympic M&A, he helps owners evaluate their options, prepare for buyer conversations, and navigate the terms and transition of a sale.